May 16th Highlights

• Cannabis, Uber and the Business Giants - This month Uber CEO Dara Khosrowshahi told CNBC last month his company “absolutely” would explore cannabis delivery if the federal government legalizes marijuana. Elizabeth Ashford, senior director of corporate communications at California-based retailer and delivery company Eaze commented on this saying “When companies like Uber are talking about getting into cannabis delivery, it’s a really good market signal about how ubiquitous cannabis legalization is and also how ubiquitous customer demand is for delivered cannabis products”. Uber and other large giants have eyed off the cannabis industry this includes Jazz Pharma, Constellation Brands, British American Tobacco, Novartis, Altria, and Molson Coors Brewing - to name a few. As governments around the world loosen regulations, and patient/consumer numbers grow, the involvement of big-name giants will increase.
• Tilray - the New Cannabis Giant - It’s going to be interesting to witness the unfolding of the new cannabis giant Tilray. In early May Tilray shareholders approved the merger with Aphri, creating a cannabis powerhouse that’s both the largest medical cannabis company in Europe and a major player in Canada’s recreational market. The company will now have a market value in excess of $8 billion. The cannabis industry will be watching to see how the company deploys its capital and executes on R&D and commercial strategies. #ThePressureIsOn - More on this topic

NZ Govt dismisses calls for medicinal cannabis review to be widened

Ryah Group enters New Zealand market signing agreement with Medical Kiwi

Emyria granted TGA approval for medical grade, smartphone-enabled, monitoring software

Medicinal cannabis research gets $1.5m for cancer treatment symptoms

Puro aims to write ‘organic playbook’ for cannabis cultivation

Health House gains foothold in Germany with CanPharma deal

‘Serious risk to your health’: Black market warning on medicinal cannabis